Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age
- PMID: 19907180
- PMCID: PMC2853583
- DOI: 10.1159/000255600
Apolipoprotein E genotype modifies the association between midlife lung function and cognitive function in old age
Abstract
Background/aims: Because poor lung function may be a risk factor for cognitive decline, we aimed to test the association of respiratory function with cognitive function and dementia later in life, as well as potential effect modification by APOE epsilon4 carrier status.
Methods: In a prospective population-based cohort study, forced vital capacity and forced expiratory flow were measured around 1965 in 857 men aged 45-64 years (394 from Finland, 208 from The Netherlands, and 255 from Italy). The Mini-Mental State Examination scores around 1990, 1995 and 2000 were analyzed using multilevel regression models and the Clinical Dementia Rating score around 1990 using multinomial logistic regression analyses.
Results: Midlife lung function was positively associated with cognitive function in old age in APOE epsilon4 non-carriers, but not in carriers (p < 0.05 for interaction). In Finland and Italy, 18.6% had questionable to mild dementia and 2.8% moderate to severe dementia after 25 years of follow-up. Dementia was inversely related to midlife lung function in APOE epsilon4 non-carriers, but not in carriers (p < 0.05 for interaction).
Conclusions: Small lung volumes were prospectively associated with an increased risk for poor cognitive function and dementia in non-carriers of the APOE epsilon4 gene.
Copyright 2009 S. Karger AG, Basel.
Figures

Similar articles
-
Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.Neurol Res. 2006 Sep;28(6):650-6. doi: 10.1179/016164106X130443. Neurol Res. 2006. PMID: 16945218
-
The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.Alzheimers Res Ther. 2021 Jan 4;13(1):5. doi: 10.1186/s13195-020-00740-0. Alzheimers Res Ther. 2021. PMID: 33397450 Free PMC article.
-
Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength.Am J Geriatr Psychiatry. 2013 Oct;21(10):1010-9. doi: 10.1016/j.jagp.2013.01.035. Epub 2013 Feb 6. Am J Geriatr Psychiatry. 2013. PMID: 23567378
-
Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Dement Geriatr Cogn Disord. 2018;45(5-6):335-352. doi: 10.1159/000490175. Epub 2018 Jul 24. Dement Geriatr Cogn Disord. 2018. PMID: 30041236
-
The effects of cardiovascular risk factors on cognitive compromise.Dialogues Clin Neurosci. 2009;11(2):201-12. doi: 10.31887/DCNS.2009.11.2/msbeeri. Dialogues Clin Neurosci. 2009. PMID: 19585955 Free PMC article. Review.
Cited by
-
Cognition and health in African American men.J Aging Health. 2015 Mar;27(2):195-219. doi: 10.1177/0898264314543474. Epub 2014 Jul 21. J Aging Health. 2015. PMID: 25053802 Free PMC article.
-
The dynamic relationship between physical function and cognition in longitudinal aging cohorts.Epidemiol Rev. 2013;35(1):33-50. doi: 10.1093/epirev/mxs004. Epub 2013 Jan 24. Epidemiol Rev. 2013. PMID: 23349427 Free PMC article.
-
Association between cardiopulmonary function, health-related quality of life and cognitive impairment among the older nursing home residents in Shanghai, China.Prim Health Care Res Dev. 2023 Mar 15;24:e18. doi: 10.1017/S1463423623000075. Prim Health Care Res Dev. 2023. PMID: 36919826 Free PMC article.
-
Association of lung function with cognitive decline and dementia: the Atherosclerosis Risk in Communities (ARIC) Study.Eur J Neurol. 2011 Jun;18(6):888-98. doi: 10.1111/j.1468-1331.2010.03340.x. Epub 2011 Jan 18. Eur J Neurol. 2011. PMID: 21244584 Free PMC article.
-
Association of apolipoprotein E polymorphism with maximal oxygen uptake after exercise training: a study of Chinese young adult.Lipids Health Dis. 2014 Feb 27;13:40. doi: 10.1186/1476-511X-13-40. Lipids Health Dis. 2014. PMID: 24571688 Free PMC article.
References
-
- Cummings JL. Alzheimer's disease. N Engl J Med. 2004;351:56–67. - PubMed
-
- Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002;156:445–453. - PubMed
-
- de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3:184–190. - PubMed
-
- Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carbonin P. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest. 1997;112:1506–1513. - PubMed
-
- Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160:50–56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous